Antimicrobial shortages are monitored by the ADSP team and if adjustments to prescribing are needed, this page will be updated.
Current Shortages Requiring Action or Therapy Modification | Updated July 2023
Intravenous clindamycin:
Clindamycin (IV) is on national backorder and supply across NM system is at risk requiring modification to conserve supply.
Recommendations:
Use oral clindamycin when appropriate.
Cefazolin is safe to use for patients unless allergy reaction history is known to be anaphylactic, TEN, or SJS to a penicillin or cephalosporin for surgical prophylaxis or SSTI treatment.
Please refer to the Infection Treatment Order Set in EPIC for alternatives based on indication.
Reach out to the local ADSP or clinical pharmacist if other alternative recommendations are needed.
Conventional Amphotericin B (deoxycholate)
Recent Shortages with Adequate Supply | Updated February 2023
Oral neomycin tablets
Influenza antivirals including oseltamivir (Tamiflu)
Additional Questions
If you have additional questions or feedback, please email adsp@nm.org
